(Drug Name) (Drug Form) (Drug Strength)
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

ARNUITY ELLIPTA: Inhalation powder (100mcg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

FLUTICASONE (floo TIK a sone) inhalation powder is a corticosteroid. It helps decrease inflammation in your lungs. This medicine is used to treat the symptoms of asthma. Never use this medicine for an acute asthma attack.

In-Depth Information

ARNUITY ELLIPTA 100mcg/actuation Powder for Inhalation

NDC: 001730874
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Asthma

Storage Information
Store in a dry place
Store between 68 to 77 degrees F, excursions permitted 59 to 86 degrees F
Avoid direct heat and sunlight
ARNUITY ELLIPTA 100mcg/actuation Powder for Inhalation

Reported Side Effects for ARNUITY ELLIPTA 100mcg/actuation Powder for Inhalation

Rhinitis Incidence:
<13.0%*
Severity: MILD
Onset: EARLY
Inflamed Hair Follicles Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Sinus Infection Incidence:
<33.0%*
Severity: MILD
Onset: DELAYED
Lightheadedness Incidence:
1.0-3.0%*
Severity: MILD
Onset: EARLY
Sneezing Incidence:
1.0-3.0%*
Severity: MILD
Onset: EARLY
Headache Incidence:
1.0-34.0%*
Severity: MILD
Onset: EARLY
Conjunctivitis Incidence:
1.0-3.0%*
Severity: MODERATE
Onset: DELAYED
Inflamed Vocal Cords Incidence:
1.0-3.0%*
Severity: MILD
Onset: DELAYED
Migraine Incidence:
1.0-3.0%*
Severity: MODERATE
Onset: EARLY
Runny Nose Incidence:
1.0-3.0%*
Severity: MILD
Onset: EARLY
Muscle And/Or Bone Pain Incidence:
1.0-12.0%*
Severity: MILD
Onset: EARLY
Nose Bleed Incidence:
1.0-6.9%*
Severity: MILD
Onset: DELAYED
Itching Incidence:
1.0-6.0%*
Severity: MILD
Onset: RAPID
Sore Throat Incidence:
1.0-25.0%*
Severity: MILD
Onset: DELAYED
Eye Irritation Incidence:
1.0-3.0%*
Severity: MILD
Onset: RAPID
Allergic Skin Reaction Incidence:
1.0-3.0%*
Severity: MODERATE
Onset: DELAYED
Back Pain Incidence:
1.0-4.0%*
Severity: MILD
Onset: DELAYED
Skin Rash Incidence:
1.0-8.0%*
Severity: MILD
Onset: EARLY
Cough Incidence:
1.0-9.0%*
Severity: MILD
Onset: DELAYED
Hoarseness Incidence:
2.0-19.0%*
Severity: MODERATE
Onset: DELAYED
Hoarseness Incidence:
2.0-9.0%*
Severity: MILD
Onset: EARLY
Nasal Irritation Incidence:
2.4-3.2%*
Severity: MILD
Onset: EARLY
Inability To Sleep Incidence:
3.0-13.0%*
Severity: MILD
Onset: EARLY
Throat Irritation Incidence:
3.0-22.0%*
Severity: MILD
Onset: EARLY
Stuffy Nose Incidence:
4.0-22.0%*
Severity: MILD
Onset: EARLY
Tired Incidence:
16.0-28.0%*
Severity: MILD
Onset: EARLY
Feeling Sick Incidence:
16.0-28.0%*
Severity: MILD
Onset: EARLY
Joint Pain Incidence:
17.0%*
Severity: MILD
Onset: DELAYED
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Compatible - This drug is generally safe to take by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with ARNUITY ELLIPTA

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5